Inhibitory effect of magnetic Fe₃O₄ nanoparticles coloaded with homoharringtonine on human leukemia cells in vivo and in vitro

References

• GremJLChesonBDKingSALeyland-JonesBSuffnessMCephalotaxine esters: anti-leukemic advance or therapeutic failure?J Natl Cancer Inst19888014109511033045335
   PubMedGoogle Scholar
• Cephalotaxus Research Coordinating GroupCephalotaxine esters in the treatment of acute leukemia. A preliminary clinical assessmentChin Med J (Engl)19762263272825360
   PubMed Web of Science ®Google Scholar
• PowellRGWeislederDSmithCRJrAntitumor alkaloids for Cephalataxus harringtonia: structure and activityJ Pharm Sci1972618122712305050371
   PubMed Web of Science ®Google Scholar
• O’BrienSKantarjianHKeatingMHomoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phaseBlood1995869332233267579434
   PubMed Web of Science ®Google Scholar
• O’BrienSKantarjianHKollerCSequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemiaBlood199993124149415310361112
   PubMed Web of Science ®Google Scholar
• DrukerBJGuilhotFO’BrienSGIRIS InvestigatorsFive-year followup of patients receiving imatinib for chronic myeloid leukemiaN Engl J Med2006355232408241717151364
   PubMed Web of Science ®Google Scholar
• DrukerBJTamuraSBuchdungerEEffects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cellsNat Med1996255615668616716
   PubMed Web of Science ®Google Scholar
• ChenYHuYMichaelsSSegalDBrownDLiSInhibitory effects of homoharringtonine on leukemic stem cells and BCR-ABL induced chronic myeloid leukemia and acute lymphoblastic leukemia in miceLeukemia20092381446145419322212
   PubMed Web of Science ®Google Scholar
• YinjunLJieJWeilaiXXiangmingTHomoharringtonine mediates myeloid cell apoptosis via up-regulation of pro-apoptotic bax and inducing caspase-3-mediated cleavage of poly (ADP-ribose) polymerase (PARP)Am J Hematol200476319920415224352
   PubMed Web of Science ®Google Scholar
• LouYJQianWBJinJHomoharringtonine induces apoptosis and growth arrest in human myeloma cellsLeuk Lymphoma20074871400140617613769
   PubMed Web of Science ®Google Scholar
• GürelGBlahaGMoorePBSteitzTAU2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosomeJ Mol Biol2009389114615619362093
   PubMed Web of Science ®Google Scholar
• TangRFaussatAMMajdakPSemisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cellsMol Cancer Ther20065372373116546987
   PubMed Web of Science ®Google Scholar
• StewartJAKrakoffIHHomoharringtonine: a phase I evaluationInvest New Drugs1985332792864066221
   PubMed Web of Science ®Google Scholar
• WhitacreMYVan EchoDAApplefeldMPhase I study of homoharringtonine (NSC 141–633)Proc Am Soc Clin Oncol198526359
   Google Scholar
• WerleMNatural and synthetic polymers as inhibitors of drug efflux pumpsPharm Res200825350051117896100
   PubMed Web of Science ®Google Scholar
• DuncanRPolymer conjugates as anticancer nanomedicinesNat Rev Cancer20066968870116900224
   PubMed Web of Science ®Google Scholar
• FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer20055316117115738981
   PubMed Web of Science ®Google Scholar
• ZhangRWangXWuCSynergistic enhancement effect of magnetic nanoparticles on anticancer drug accumulation in cancer cellsNanotechnology200617143622362619661614
   PubMed Web of Science ®Google Scholar
• BriggerIDubernetCCouvreurPNanoparticles in cancer therapy and diagnosisAdv Drug Deliv Rev200254563165112204596
   PubMed Web of Science ®Google Scholar
• JohnTAVogelSMTiruppathiCMalikABMinshallRDQuantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayerAm J Physiol Lung Cell Mol Physiol20032841L187L19612471015
   PubMed Web of Science ®Google Scholar
• JainTKMoralesMASahooSKLeslie-PeleckyDLLabhasetwarVIron oxide nanoparticles for sustained delivery of anticancer agentsMol Pharm20052319420515934780
   PubMed Web of Science ®Google Scholar
• XiongFZhuJBWangWHuaXBDetermination of entrapment efficiency of breviscapinenanoliposomesActa Pharm Sin2004399755757
   Google Scholar
• YangMYangCMaJBianSXueYDetermination of the content of homoharringtonine in serum by HPLCChin J Pharm Anal1999193147149
   Google Scholar
• HuangBTZengQCYuJLiuXLXiaoZZhuHQHigh-dose homoharringtonine versus standard-dose daunorubicin is effective and safe as induction and postinduction chemotherapy for elderly patients with acute myeloid leukemia: a multicenter experience from ChinaMed Oncol201229125125921258877
   PubMed Web of Science ®Google Scholar
• WangJLüSYangJA homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from ChinaJ Hematol Oncol200923219642997
   PubMed Web of Science ®Google Scholar
• JinJWangJXChenFFHomoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trialLancet Oncol201314759960823664707
   PubMed Web of Science ®Google Scholar
• ReedJCPellecchiaMApoptosis-based therapies for hematologic malignanciesBlood2005106240841815797997
   PubMed Web of Science ®Google Scholar
• BressenotAMarchalSBezdetnayaLGarrierJGuilleminFPlénatFAssessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinomaJ Histochem Cytochem200957428930019029405
   PubMed Web of Science ®Google Scholar
• PanJQuintás-CardamaAManshouriTThe novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-α-expressing cells through caspase-3-mediated cleavage of Mcl-1Leukemia2007211395140417495975
   PubMed Web of Science ®Google Scholar
• DasmahapatraGYerramNDaiYDentPGrantSSynergistic interactions between vorinostat and sorafenib in chronic myelogenous leukemia cells involve Mcl-1 and p21CIP1 down-regulationClin Cancer Res200713144280429017634558
   PubMed Web of Science ®Google Scholar
• AnkamwarBLaiTCHuangJHBiocompatibility of Fe(3)O(4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cellsNanotechnology20102177510220090199
   PubMed Web of Science ®Google Scholar
• KarlssonHLGustafssonJCronholmPMöllerLSize-dependent toxicity of metal oxide particles: a comparison between nano- and micrometer sizeToxicol Lett2009188211211819446243
   PubMed Web of Science ®Google Scholar
• KarlssonHLCronholmPGustafssonJMöllerLCopper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubesChem Res Toxicol20082191726173218710264
   PubMed Web of Science ®Google Scholar